Tenax Therapeutics, Inc. (TENX)
Tenax Therapeutics, Inc. (TENX) Insider Trading
Directors, officers and holders of more than 10% of TENX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 57 transactions on file: 29 with code P, 0 with code S and 21 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 331,979 | $1.66 | $550,687 |
| Oct 20, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 254,342 | $1.60 | $405,726 |
| Oct 19, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 336,528 | $1.51 | $507,013 |
| Sep 16, 2026 | Doogan Declan | Director | P Purchase | 53,000 | $1.92 | $101,760 |
| Sep 15, 2026 | Giordano Christopher Thomas | CEO | P Purchase | 4,850 | $1.82 | $8,837 |
| Sep 11, 2026 | Giordano Christopher Thomas | CEO | P Purchase | 6,000 | $1.88 | $11,250 |
| Sep 11, 2026 | STAAB THOMAS R II | Chief Financial Officer | P Purchase | 5,675 | $1.94 | $10,981 |
| Sep 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 900,000 | $1.78 | $1,604,160 |
| Sep 2, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 187,704 | $1.80 | $337,586 |
| Sep 1, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 179,058 | $1.80 | $321,570 |
| Aug 31, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 403,571 | $1.79 | $722,594 |
| Aug 24, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 107,374 | $1.75 | $188,355 |
| Aug 21, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 716,369 | $1.77 | $1,266,254 |
| Aug 20, 2026 | ADAR1 Capital Management, LLC | 10% Owner | P Purchase | 202,124 | $1.78 | $359,538 |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO | M Exercise | 8,500 | $5.94 | $50,490 |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO | M Exercise | 8,500 | Not measured | Not measured |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO | M Exercise | 219 | Not measured | Not measured |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO | M Exercise | 219 | $3.55 | $777 |
| May 11, 2026 | STAAB THOMAS R II | Chief Financial Officer | A Award | 10,000 | Not measured | Not measured |
| May 11, 2026 | STAAB THOMAS R II | Chief Financial Officer | A Award | 450,000 | Not measured | Not measured |
| Jan 30, 2026 | MCGAULEY THOMAS | Interim CFO | M Exercise | 50,000 | Not measured | Not measured |
| Jan 9, 2026 | PROEHL GERALD T | Director | A Award | 3,000 | Not measured | Not measured |
| Jan 9, 2026 | Rich Stuart | Chief Medical Officer | A Award | 250,000 | Not measured | Not measured |
| Jan 9, 2026 | Giordano Christopher Thomas | CEO | A Award | 450,000 | Not measured | Not measured |
| Jan 9, 2026 | Hunter Robyn | Director | A Award | 30,000 | Not measured | Not measured |
| Jan 9, 2026 | Doogan Declan | Director | A Award | 30,000 | Not measured | Not measured |
| Jan 9, 2026 | Almenoff June Sherie | Director | A Award | 30,000 | Not measured | Not measured |
| Jan 9, 2026 | Davidson Michael H. | Director | A Award | 30,000 | Not measured | Not measured |
| Dec 9, 2025 | Rich Stuart | Chief Medical Officer | P Purchase | 2,500 | $10.22 | $25,542 |
| Dec 8, 2025 | Rich Stuart | Chief Medical Officer | P Purchase | 2,500 | $10.10 | $25,250 |
| Dec 4, 2025 | Rich Stuart | Chief Medical Officer | P Purchase | 2,500 | $9.20 | $22,998 |
| Dec 3, 2025 | Rich Stuart | Chief Medical Officer | P Purchase | 1,500 | $9.08 | $13,618 |
| Dec 2, 2025 | Rich Stuart | Chief Medical Officer | P Purchase | 1,000 | $9.01 | $9,006 |
| Nov 20, 2025 | Giordano Christopher Thomas | CEO | P Purchase | 538 | $7.59 | $4,083 |
| Nov 19, 2025 | Giordano Christopher Thomas | CEO | P Purchase | 455 | $7.51 | $3,417 |
| Nov 18, 2025 | Giordano Christopher Thomas | CEO | P Purchase | 1,612 | $7.75 | $12,500 |
| Nov 18, 2025 | Almenoff June Sherie | Director | P Purchase | 1,900 | $7.52 | $14,280 |
| Nov 18, 2025 | Almenoff June Sherie | Director | P Purchase | 1,900 | $7.52 | $14,280 |
| Nov 17, 2025 | MCGAULEY THOMAS | Interim CFO | P Purchase | 1,000 | $7.35 | $7,350 |
| Nov 17, 2025 | Almenoff June Sherie | Director | P Purchase | 93 | $7.15 | $665 |
| Nov 17, 2025 | Almenoff June Sherie | Director | P Purchase | 93 | $7.15 | $665 |
| Nov 17, 2025 | MCGAULEY THOMAS | Interim CFO | P Purchase | 5,000 | $7.23 | $36,140 |
| Nov 17, 2025 | MCGAULEY THOMAS | Interim CFO | P Purchase | 2,000 | $7.34 | $14,674 |
| Jul 1, 2025 | Davidson Michael H. | Director | A Award | 80,000 | Not measured | Not measured |
| Jul 1, 2025 | Doogan Declan | Director | A Award | 80,000 | Not measured | Not measured |
| Jul 1, 2025 | PROEHL GERALD T | Director | A Award | 80,000 | Not measured | Not measured |
| Jul 1, 2025 | Hunter Robyn | Director | A Award | 80,000 | Not measured | Not measured |
| Jul 1, 2025 | Almenoff June Sherie | Director | A Award | 80,000 | Not measured | Not measured |
| May 16, 2025 | Rich Stuart | Chief Medical Officer | A Award | 625,000 | Not measured | Not measured |
| May 16, 2025 | Giordano Christopher Thomas | CEO | A Award | 1,400,000 | Not measured | Not measured |
The full Form 4 history is on the TENX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.